OP White Papers - random

  1. Placing Drug Strategies On A Solid Foundation For Success 9/3/2025

    Explore how certain drivers are impacting traditional drug development strategies and relationships with outsourced drug development and manufacturing partners.

  2. UpTempo Plasmid DNA Platform 1/28/2025

    Gain insight into these end-to-end plasmid DNA solutions, leveraging robust cGMP-compliant processes and single-use manufacturing platforms to accelerate your cell and gene therapy programs.

  3. Biomanufacturing Readiness: A Validation Model For Multiproduct Facilities 6/12/2025

    Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.

  4. The Value Of Engaging A Single CDMO For Comprehensive Biologics Services 5/16/2024

    By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.

  5. Challenges In ADC Production - Consolidating Operations Under One Roof 4/15/2025

    Eurofins CDMO Alphora consolidates ADC development and manufacturing under one roof, streamlining processes, enhancing safety, and accelerating delivery of high-quality, clinically-ready antibody-drug conjugates.

  6. Mastering Technology Transfers: Our Blueprint For Success 4/16/2025

    Uncover how this expert approach to process transfer supports reliable, scalable commercial manufacturing in the rapidly growing biopharmaceutical market.

  7. Improving Safety And Efficacy With Charged Variant Characterization 5/14/2024

    Discover how a CDMO with extensive experience in protein variant characterization, CQA analytics, and patient-centric product development can ensure the safety and efficacy of your biotherapeutic.

  8. How To Avoid Sticking And Picking In The Tableting Industry 9/23/2024

    Review strategies to mitigate sticking and picking risks in the tablet industry, and learn how you can foster improved tablet production processes, ensuring higher quality and consistency.

  9. A New Framework For Identifying Nitrosamine Risks And Derisking Products 6/18/2024

    Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.

  10. Stability Services 4/28/2025

    Dive into a summary of stability considerations and process examples for recombinant proteins, mAbs, gene therapy, and subunit vaccines.